JOURNAL OF THE CHINESE
CHEMICAL SOCIETY
Synthesis of Pipermethystine Skeletons
temperature under nitrogen were added sequentially
5-Acetoxy-4-(phenylsulfonyl)-5,6-dihydro-1H-pyri-
din-2-one (11). Compound 8 (9.5 mg, 0.036 mmol) with
3 equiv mCPBA gave compound 11 (5.7 mg 54%) as a
with a syringe Et N (0.10 mL, 0.73 mmol) and hydro-
3
cinnamoyl chloride (0.65 mL, 0.438 mmol). The reac-
tion mixture was refluxed for 24 h, and then the solvent
was removed under vacuum. Ethyl acetate (10 mL) was
added, and the organic solution was washed with 5%
HCl (10 mL) and saturated NaHCO3 (10 mL). The
organic solution was separated, and the aqueous solu-
tion was extracted with ethyl acetate (30 mL × 3), dried
ꢀ
white solid: mp 206–207 C, (recryst. ethyl acetate); IR
−1
(neat, cm ): v 3054, 2987, 2686, 2411, 2306, 1750, 1688,
1
1422, 1265, 1160, 896; H NMR (CDCl , 300 MHz,
3
ppm): δ 7.92–7.90 (2H, m), 7.74–7.69 (1H, m), 7.63–7.58
(2H, m), 7.05 (1H, d, J = 1.5 Hz), 6.43 (1H, s), 5.77 (1H,
s), 3.69 (1H, dd, J = 15, 3.3 Hz), 3.57–3.54 (1H, m), 1.68
13
(
MgSO ), and evaporated. The crude product was puri-
(3H,s); C NMR (CDCl , 75 MHz, ppm): δ 169.4, 162.4,
4
3
fied by column chromatography using ethyl acetate/hex-
ane (1:5) as eluent to give compound 9 (46.4 mg, 51%)
as a yellow oil; IR (neat, cm ): v 3054, 2987, 2930,
147.7, 138.0, 134.6, 132.4, 129.6, 128.9, 60.1, 45.5, 20.3.
5-Hydroxy-4-(phenylsulfonyl)-1-tosyl-5,6-dihydro-
−1
1H-pyridin-2-one
(12).
Compound
2
(70 mg,
2
8
855, 2305, 1746, 1682, 1603, 1421, 1265, 1078, 1043,
0.186 mmol) with 3 equiv mCPBA gave compound 12
1
ꢀ
96; H NMR (CDCl , 300 MHz, ppm): δ 7.64–7.45
(43.2 mg 57%) as a white solid: mp 143—146 C, (recryst.
3
−1
(
5
5H, m), 7.43–7.00 (5H, m), 5.76 (1H, t, J = 4.2 Hz),
.37 (1H, s), 4.47 (1H, dd, J = 14.4, 4.2 Hz), 3.76 (1H,
dd, J = 14.4, 3.6 Hz), 3.32–3.14 (2H, m), 3.00–2.94
ethyl acetate); IR (neat, cm ): v 3301, 3054 , 2987, 2685,
1
2521, 2305, 1697, 1551, 1265, 1156, 896; H NMR
(CDCl , 300 MHz, ppm): δ 7.93–7.91 (4H, m), 7.83–7.72
3
1
3
(2H, m), 2.12 (3H, s); C NMR (CDCl , 75 MHz,
(1H, m), 7.64–7.56 (2H, m), 7.33–7.31 (2H, m), 6.35 (1H,
s), 4.71–4.64 (2H, m), 3.73 (1H, dd, J = 13.8, 3 Hz), 3.00
3
ppm): δ 175.3, 169.7, 162.6, 157.3, 141.0, 135.4, 130.6,
13
1
3
3
1
3
30.2, 128.5, 128.3, 126.9, 126.0, 118.0, 65.0, 45.3, 40.5,
(1H, s), 2.43 (3H, s); C NMR (CDCl , 75 MHz, ppm):
3
0.9, 20.8; FAB-MS (relative intensity): m/z
δ 159.7, 153.1, 145.6, 136.8, 135.1, 134.8, 133.6, 129.8,
129.5, 129.0, 128.8, 60.4, 50.5, 21.7.
+
96 (M +H, 0.83), 376 (1), 342 (1), 249 (20), 228, (45),
+
66 (30); Exact mass Calcd for C H NO S (M )
2
2
21
4
15
General preparation of Al/Hg reagent
95.1191, FAB-HRMS m/z 395.1195.
An aluminum foil was cut to the size 2 × 1 cm
(
1
10 mg), put it in 5% NaOH aqueous solution for
min, and then washed by distilled water quickly. The
General procedure for oxidation with mCPBA
To a solution of the sulfide (0.068 mmol) in
washed aluminum foil was put in 5% HgCl aqueous
2
CH Cl2 (2 mL) in an ice bath was added mCPBA
2
solution for 1 min, followed by washing with distilled
water, ethanol, and ether.
(
70–75% in H O, 0.17 mmol). After 5 min, the ice bath
2
was removed, and the mixture was further stirred at
room temperature for 2 h. To the reaction mixture was
then added successively saturated Na S O (10 mL)
and saturated NaHCO3 (10 mL), and was extracted
with CH Cl (20 × 3 mL). The organic solution was
5
-Hydroxy-1-tosyl-5,6-dihydro-1H-pyridin-2-one
(
13) and 5-Hydroxy-1-tosylpiperidin-2-one (14). A mix-
2
2
3
ture of compound 12 (5 mg, 0.0123 mmol), Al/Hg
ꢀ
(
10 mg, 0.370 mmol) in THF (1 mL) was stirred at 0 C
2
2
for 1 day. Ethyl acetate (10 mL) was added, and the
organic solution was filtered through a flash column of
celite. The filtered solution was evaporated under vac-
uum. The crude product was purified by column chro-
matography using ethyl acetate/hexane (1:1) containing
dried over MgSO and evaporated. The crude product
was purified by column chromatography (ethyl acetate
4
/
hexane 1:1 to 2:1) to give purified sulfone products.
-Acetoxy-1-(3-phenylpropanoyl)-4-(phenylsulfo-
nyl)-5,6-dihydro-1H-pyridin-2-one (10). Compound
(26.7 mg, 0.068 mmol) with 2.5 equiv mCPBA gave
5
2
–5% Et N as eluent to give compound 13 and com-
3
9
1
pound 14 in the ratio 1:0.2 (3.4 mg, 94%).
compound 10 (7.3 mg, 25%); H NMR (CDCl3,
00 MHz, ppm): δ 7.95–7.75 (2H, m), 7.79–7.70 (1H,
m), 7.69–7.58 (2H, m), 7.48–7.11 (5H, m), 7.07 (1H, s),
3
ACKNOWLEDGMENTS
5
2
.87 (1H, t, J = 2.7 Hz), 4.74 (1H, dd, J = 15.3,
.1 Hz), 3.43 (1H, dd, J = 15.3, 2.7 Hz), 3.94–3.16
Financial support of this work by the Ministry of
Science and Technology of the Republic of China (NSC
101-2113-M-030-001-MY2) is gratefully acknowledged.
(2H, m), 3.07–2.89 (2H, m), 1.60 (3H, s).
J. Chin. Chem. Soc. 2016, 63, 818–824
© 2016 The Chemical Society Located in Taipei & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.jccs.wiley-vch.de
823